ロード中...

Examination of Diagnostic Accuracy of UroVysion Fluorescence In Situ Hybridization for Bladder Cancer in a Single Community of Japanese Hospital Patients

OBJECTIVE: UroVysion (Abbott Molecular, Inc., Illinois, USA) is based on multicolor fluorescence in situ hybridization (FISH). It has been used successfully in the USA following its Food and Drug Administration approval in 2001. However, the technology was not approved for use in Japan until 2017. C...

詳細記述

保存先:
書誌詳細
出版年:Asian Pac J Cancer Prev
主要な著者: Nagai, Takashi, Okamura, Takehiko, Yanase, Takahiro, Chaya, Ryosuke, Moritoki, Yoshinobu, Kobayashi, Daichi, Akita, Hidetoshi, Yasui, Takahiro
フォーマット: Artigo
言語:Inglês
出版事項: West Asia Organization for Cancer Prevention 2019
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6948889/
https://ncbi.nlm.nih.gov/pubmed/31030505
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31557/APJCP.2019.20.4.1271
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!